Long non-coding RNA lincRNA-erythroid prosurvival attenuates inflammation by enhancing myosin heavy chain 6 stability through recruitment of heterogeneous nuclear ribonucleoprotein L in myocardial infarction

References

• Denmark KT, Usa J, Usa A, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231–2264.
   PubMedGoogle Scholar
• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation. 2018;137:e67–e492.
   PubMed Web of Science ®Google Scholar
• Boag SE, Andreano E, Spyridopoulos I. Lymphocyte communication in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2017;26:660–675.
   PubMed Web of Science ®Google Scholar
• Libby P, Nahrendorf M, Swirski FK. Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded “Cardiovascular Continuum”. J Am Coll Cardiol. 2016;67:1091–1103.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Z, Ding Z, et al. Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Assoc. 2018;7. DOI:10.1161/JAHA.117.008024
   Google Scholar
• Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423–437.
   PubMed Web of Science ®Google Scholar
• Ying H. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell & Mol Med. 2018;22:5768–5775.
   PubMed Web of Science ®Google Scholar
• Morchikh M, Cribier A, Raffel R, et al. HEXIM1 and NEAT1 long non-coding RNA form a multi-subunit complex that regulates DNA-Mediated innate immune response. Mol Cell. 2017;67:387–99 e5.
   PubMed Web of Science ®Google Scholar
• Murphy MB, Medvedev AE. Long noncoding RNAs as regulators of Toll-like receptor signaling and innate immunity. J Leukoc Biol. 2016;99:839–850.
   PubMed Web of Science ®Google Scholar
• Yang J, Huang X, Hu F, et al. LncRNA ANRIL knockdown relieves myocardial cell apoptosis in acute myocardial infarction by regulating IL-33/ST2. Cell Cycle. 2019;18:3393–3403.
   PubMed Web of Science ®Google Scholar
• Li T, Tian H, Li J, et al. Overexpression of lncRNA Gm2691 attenuates apoptosis and inflammatory response after myocardial infarction through PI3K/Akt signaling pathway. IUBMB Life. 2019;71:1561–1570.
   PubMed Web of Science ®Google Scholar
• Hu W, Yuan B, Flygare J, et al. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev. 2011;25:2573–2578.
   PubMed Web of Science ®Google Scholar
• Atianand M, Hu W, Satpathy A, et al. A long noncoding RNA lincrna-eps acts as a transcriptional brake to restrain inflammation. Cell. 2016;165:1672–1685.
   PubMed Web of Science ®Google Scholar
• Luo X, Deng C, Liu F, et al. HnRNPL promotes Wilms tumor progression by regulating the p53 and Bcl2 pathways. Onco Targets Ther. 2019;12:4269–4279.
   PubMed Web of Science ®Google Scholar
• Yu Z, Tang PL, Wang J, et al. Mutations in Hnrnpa1 cause congenital heart defects. JCI Insight. 2018;3:e98555.
   PubMed Web of Science ®Google Scholar
• Fei T, Chen Y, Xiao T, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc Natl Acad Sci U S A. 2017;114:E5207–E15.
   PubMed Web of Science ®Google Scholar
• Cao J, Routh AL, Kuyumcu-Martinez MN. Nanopore sequencing reveals full-length Tropomyosin 1 isoforms and their regulation by RNA-binding proteins during rat heart development. J Cell Mol Med. 2021;25:8352–8362.
   PubMed Web of Science ®Google Scholar
• Tomita-Mitchell A, Stamm KD, Mahnke DK, et al. Impact of MYH6 variants in hypoplastic left heart syndrome. Physiol Genomics. 2016;48:912–921.
   PubMed Web of Science ®Google Scholar
• Chen JH, Wang LL, Tao L, et al. Identification of MYH6 as the potential gene for human ischaemic cardiomyopathy. J Cell Mol Med. 2021;26:25.
   PubMedGoogle Scholar
• Lahnwong S, Palee S, Apaijai N, et al. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury. Cardiovasc Diabetol. 2020;19:19.
   PubMed Web of Science ®Google Scholar
• Ou R, Lv J, Zhang Q, et al. circAMOTL1 Motivates AMOTL1 Expression to Facilitate Cervical Cancer Growth. Mol Ther Nucleic Acids. 2019;19:50–60.
   PubMedGoogle Scholar
• Liu Z, Liu J, Wei Y, et al. LncRNA MALAT1 prevents the protective effects of miR125b5p against acute myocardial infarction through positive regulation of NLRC5. Exp Ther Med. 2020;19:990–998.
   PubMed Web of Science ®Google Scholar
• Mao Q, Liang XL, Zhang CL, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10:393.
   PubMed Web of Science ®Google Scholar
• Guo J, Chen M, Ai G, et al. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047. Biomed Pharmacother. 2019;115:108957.
   PubMed Web of Science ®Google Scholar
• Mao Y, Zhang L, Li Y. circEIF4G2 modulates the malignant features of cervical cancer via the miR-218/HOXA1 pathway. Mol Med Rep. 2019;19:3714–3722.
   PubMed Web of Science ®Google Scholar
• Rong X, Gao W, Yang X, et al. Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling. Life Sci. 2019;235:116785.
   PubMed Web of Science ®Google Scholar
• The L. Acute myocardial infarction in women. Lancet. 2016;387:506.
   Web of Science ®Google Scholar
• Lagan Lekarz J, Naish JH, Simpson K, et al. Substrate for the myocardial inflammation-heart failure hypothesis identified using novel uspio methodology. JACC Cardiovasc Imaging. 2021;14:365–376.
   PubMed Web of Science ®Google Scholar
• Williams DM, Shroff GR, Leclaire MM, et al. Shock after myocardial infarction. Chest. 2018;153:e29–e31.
   PubMed Web of Science ®Google Scholar
• Lim GB. Acute coronary syndromes: supplemental oxygen in myocardial infarction. Nat Rev Cardiol. 2017;14:632.
   Google Scholar
• Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5:1841–1875.
   PubMed Web of Science ®Google Scholar
• Ye J, Beetz N, O’Keeffe S, et al. hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function. Proc Natl Acad Sci U S A. 2015;112:E3020–9.
   PubMed Web of Science ®Google Scholar
• Bilbao D, Valcarcel J. Getting to the heart of a splicing enhancer. Nat Struct Biol. 2003;10:6–7.
   PubMedGoogle Scholar
• Granados-Riveron JT, Ghosh TK, Pope M, et al. Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet. 2010;19:4007–4016.
   PubMed Web of Science ®Google Scholar
• Theis JL, Zimmermann MT, Evans JM, et al. Recessive MYH6 mutations in hypoplastic left heart with reduced ejection fraction. Circ Cardiovasc Genet. 2015;8:564–571.
   PubMedGoogle Scholar